VR for the Reduction of Perioperative Anxiety
Assessment and Minimization of Preoperative Fear of the Unknown Using a VR Experience of the Theatre Suite; a Randomized Control Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The study, set to take place at Gold Coast University Hospital in Australia, will be conducted as a randomized controlled trial. Patients preparing for gynecological cancer surgery will be recruited and randomly assigned to one of two groups: those who will receive standard care plus a virtual reality (VR) intervention, and those who will receive only standard care. Standard care encompasses the usual pre-operative procedures and support provided by the hospital staff. We hypothesize that immersing patients in a preparatory virtual environment that shows them what they are to expect during their upcoming hospital stay for surgery, could help reduce their anxiety levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2022
CompletedFirst Submitted
Initial submission to the registry
April 26, 2024
CompletedFirst Posted
Study publicly available on registry
May 1, 2024
CompletedMay 31, 2024
May 1, 2024
2.7 years
April 26, 2024
May 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety
Anxiety level measured by a 6-item visual scale (1 .. least anxiety, 6 ... highest anxiety)
T0 (before randomization), T1 (same day as T0, but after care as usual +/- VR; usually inside 1 hour), T2 (days/weeks later, before surgical procedure - exact gap is unknown; expected: >3 days, median around 4-7 weeks)
Study Arms (2)
Virtual reality
EXPERIMENTALCare-as-usual + virtual reality intervention during a pre-operative visit
Control
NO INTERVENTIONCare-as-usual during a pre-operative visit
Interventions
An immersive VR experience, delivered using a VR head-mounted display, of the real-world environment at the hospital, featuring the pre-operative admission suite, pre-anesthetic bay, operating theatre, postoperative recovery room, and medical staff.
Eligibility Criteria
You may qualify if:
- Gynecological oncology patients with scheduled surgery
You may not qualify if:
- Language barrier
- Inability to provide consent
- Having undergone any procedure at the operating theatre in the previous 5 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruhr University of Bochumlead
- Gold Coast Hospital and Health Servicecollaborator
Study Sites (1)
Gold Coast University Hospital
Southport, Queensland, 4215, Australia
Related Publications (2)
Cao X, Yumul R, Elvir Lazo OL, Friedman J, Durra O, Zhang X, White PF. A novel visual facial anxiety scale for assessing preoperative anxiety. PLoS One. 2017 Feb 14;12(2):e0171233. doi: 10.1371/journal.pone.0171233. eCollection 2017.
PMID: 28196099BACKGROUNDSchmid BC, Marsland D, Jacobs E, Rezniczek GA. A Preparatory Virtual Reality Experience Reduces Anxiety before Surgery in Gynecologic Oncology Patients: A Randomized Controlled Trial. Cancers (Basel). 2024 May 17;16(10):1913. doi: 10.3390/cancers16101913.
PMID: 38791991RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernd C Schmid, MD
Gold Coast University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Care provider measuring the primary outcome scale at T2 was not aware of the intervention given at T0/1. Statistical data analysis initially was prepared not knowing which group was the intervention group.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Ob/Gyn Research Lab (MHH)
Study Record Dates
First Submitted
April 26, 2024
First Posted
May 1, 2024
Study Start
May 10, 2019
Primary Completion
February 4, 2022
Study Completion
February 4, 2022
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- After publication
- Access Criteria
- Reasonable request; approval of intended use by an Institutional Review Board
De-identified data will be shared upon reasonable request for purposes that have been approved by the respective Institutional Review Board